| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,083 |
14,994 |
$786K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,011 |
3,410 |
$208K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
5,033 |
4,293 |
$100K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
599 |
541 |
$40K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,056 |
1,535 |
$33K |
| 99442 |
|
414 |
314 |
$4K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
135 |
115 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
256 |
212 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
47 |
42 |
$3K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
129 |
111 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
50 |
34 |
$1K |
| Q3014 |
Telehealth originating site facility fee |
91 |
73 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
56 |
54 |
$649.38 |
| 87634 |
|
37 |
25 |
$470.34 |
| 81002 |
|
27 |
24 |
$79.86 |
| 90723 |
|
17 |
13 |
$32.44 |